GLP-1 medications carry black box warnings and potential side effects commonly including nausea, vomiting, diarrhea, constipation, and abdominal pain and require ongoing medical supervision
GLP1 receptor agonists reduce hunger through three pathways that work simultaneously: Brain signaling : GLP1 receptors in the hypothalamus and brainstem regulate hunger and satiety
Maximum benefits are usually seen within the first six months, and its usefulness beyond four years has not yet been well studied
Methods: We searched the Web of Science, Cochrane Central Register of Controlled Trials, PubMed, PsycINFO, and Scopus for relevant Randomized Clinical trials (RCTs) from inception until 1 August 2022
This mechanism complements the angiogenic and proliferative effects of the peptide, ensuring that new cells not only form but also reach the locations where they are needed